Chronic respiratory failure with hypoxia
ICD-10 J96.11 is a billable code used to indicate a diagnosis of chronic respiratory failure with hypoxia.
Chronic respiratory failure with hypoxia is a condition characterized by the inability of the respiratory system to maintain adequate gas exchange, leading to low oxygen levels in the blood (hypoxemia). This condition often arises from chronic lung diseases such as Chronic Obstructive Pulmonary Disease (COPD), interstitial lung disease, or pulmonary hypertension. The anatomy involved includes the lungs, alveoli, and the pulmonary vasculature, which are crucial for oxygen uptake and carbon dioxide elimination. Disease progression typically involves a gradual decline in respiratory function, often exacerbated by acute infections or environmental factors. Patients may present with symptoms such as dyspnea, fatigue, and cyanosis. Diagnostic considerations include arterial blood gas analysis, pulmonary function tests, and imaging studies to assess lung structure and function. Management often requires supplemental oxygen therapy, bronchodilators, and in some cases, non-invasive ventilation to support breathing and improve oxygenation.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
J96.11 encompasses chronic respiratory failure due to conditions such as COPD, pulmonary fibrosis, and other chronic lung diseases that result in sustained hypoxemia. It is essential to document the underlying cause to support the diagnosis.
J96.11 should be used when the patient has chronic respiratory failure specifically characterized by hypoxia. If hypercapnia is present, J96.12 should be considered. Accurate differentiation is crucial for appropriate management and billing.
Documentation should include clinical findings such as arterial blood gas results indicating hypoxemia, evidence of chronic lung disease, and treatment plans that reflect ongoing management of respiratory failure.
